Clinical Trial Update: Irofulven in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating irofulven in patients with stage IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Irofulven (irofulven)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED